@article{france_yogarajah_gueiros_valdez_mays_posey_payne_setterfield_sollecito_woo_et al._2022, title={World Workshop on Oral Medicine VII: Oral adverse effects to biologic agents in patients with inflammatory disorders. A scoping review}, ISSN={["1600-0714"]}, DOI={10.1111/jop.13389}, abstractNote={Abstract}, journal={JOURNAL OF ORAL PATHOLOGY & MEDICINE}, author={France, Katherine and Yogarajah, Sangeetha and Gueiros, Luiz Alcino and Valdez, Remberto and Mays, Jacqueline W. and Posey, Rachael and Payne, Aimee S. and Setterfield, Jane and Sollecito, Thomas P. and Woo, Sook-Bin and et al.}, year={2022}, month={Dec} }
 @article{frias-de-diego_posey_pecoraro_carnevale_beaty_crisci_2020, title={A Century of Swine Influenza: Is It Really Just about the Pigs?}, volume={7}, url={http://dx.doi.org/10.3390/vetsci7040189}, DOI={10.3390/vetsci7040189}, abstractNote={Influenza viruses (IV) are one of the major threats to human and animal health worldwide due to the variety of species they affect. Pigs play an important role in IV ecology as the “mixing vessel,” since they can be infected by swine, avian and human IV, allowing the appearance of new subtypes. Human viruses originated in swine are known as IV of swine origin or swine influenza virus (SwIV) variants. In this study, we identified knowledge tendencies of SwIV and assessed potential bias in the literature caused by these variants. We identified the most mentioned SwIV variants and manually reviewed the literature to determine the number of publications applying the whole influenza nomenclature, a partial nomenclature, only the subtype or mixed terminology, along with the proportion of articles in which the GenBank ID number was available. We observed that the 2009 H1N1 human pandemic created an important bias in SwIV research driven by an increase in human publications on the IV of swine origin. H1N1 is the most studied subtype for swine and humans, followed by H3N2. We found differences between the nomenclatures applied, where partial classifications were slightly more common. Finally, from all the publications, only 25% stated the GenBank ID of the sequence studied. This review represents the most complete exploration of trends in SwIV knowledge to date and will serve as a guidance for future search strategies in SwIV research.}, number={4}, journal={Veterinary Sciences}, publisher={MDPI AG}, author={Frias-De-Diego, Alba and Posey, Rachael and Pecoraro, Brittany M. and Carnevale, Rafaella Fernandes and Beaty, Alayna and Crisci, Elisa}, year={2020}, month={Nov}, pages={189} }
 @article{hopewell_harrison_posey_duke_troan_harrison_2020, title={Analysis of Published Amphibian Neoplasia Case Reports}, volume={30}, url={http://dx.doi.org/10.5818/19-09-212.1}, DOI={10.5818/19-09-212.1}, abstractNote={Abstract Neoplasia due to environmental contaminants has been previously reported in wild amphibians; however, minimal research has been done to investigate individual cases of amphibian neoplasia independent of environmental contamination or viral etiologies. This study reviewed published literature for neoplasia in amphibians in order to supplement the Exotic Species Cancer Research Alliance (ESCRA) database. Through searches of three scientific literature databases (PubMed, CAB Abstracts, and Web of Science Zoological Record), 50 cases of amphibian neoplasia were found in 36 articles published between 1954 and 2018. The most common species reported were African clawed frogs (Xenopus laevis; n = 8) and axolotls (Ambystoma mexicanum; n = 6). Of the 50 cases, 27 of the neoplasms were malignant and 23 benign, with the majority of the malignant cases being localized (n = 17). Chromatophoroma (n = 9), lymphoma/leukemia (n = 6), and papilloma (n = 5) were the most frequently reported neoplasms, and skin (n = 24) and the hemolymphatic system (n = 6) were the most common locations. No treatment was provided for the majority (69%) of these cases. When treatment was provided, surgical excision was most frequently chosen and was associated with a better prognosis (n = 12, P < 0.001). Males and amphibians with benign neoplasms were more likely to have a better prognosis (P = 0.049 in a literature data set spanning 1954–2018 and P = 0.019 for 1970–2018), and animals with malignant neoplasms were more likely to have a poor prognosis (P = 0.036 for a literature data set spanning 1970–2018). This analysis of neoplasia in amphibians enables us to evaluate published cases of amphibian neoplasia to extend the analytical power of resources such as the ESCRA database and provide insight into prognostic factors of neoplasia in amphibian species.}, number={3}, journal={Journal of Herpetological Medicine and Surgery}, publisher={Association of Reptilian and Amphibian Veterinarians (ARAV)}, author={Hopewell, Elizabeth and Harrison, Scott H. and Posey, Rachael and Duke, Elizabeth G. and Troan, Brigid and Harrison, Tara}, year={2020}, month={Oct} }
 @article{tschoepe_benfield_mercer_posey_2019, title={Systematic Review of Community Transition Programs After Acute Rehabilitation for Adults With Traumatic Spinal Cord Injury}, volume={73}, ISSN={["1943-7676"]}, DOI={10.5014/ajot.2019.73S1-RP102A}, abstractNote={Abstract}, number={4}, journal={AMERICAN JOURNAL OF OCCUPATIONAL THERAPY}, author={Tschoepe, Raheleh and Benfield, Anna and Mercer, Vicki and Posey, Rachael}, year={2019}, month={Aug} }
 @misc{patti_renfro_posey_wu_turner_ferreri_2019, title={Systematic review of medication synchronization in community pharmacy practice}, volume={15}, ISSN={["1934-8150"]}, DOI={10.1016/j.sapharm.2018.11.008}, abstractNote={Medication non-adherence costs more than 100 billion dollars in avoidable hospitalizations yearly. As a result, community pharmacies have implemented medication synchronization programs to improve adherence. One function of most medication synchronization programs is the alignment of all of a patient's medications to refill on a single date. While aligning refills is a standard aspect of most programs, other features vary making it difficult to identify which program components lead to improved adherence.To review available literature and identify core components of medication synchronization and associated implementation techniques in community pharmacy.A systematic review was performed by searching electronic databases for studies, reviews, and other sources for grey literature discussing medication synchronization in community pharmacy settings. Studies were eligible for inclusion if they documented the operation of medication synchronization program in a community pharmacy. A framework analysis identified common themes present in the literature.Twenty-six studies met criteria for final inclusion in this review. The majority of studies were retrospective cohorts, commentaries, and implementation guides. A wide variety of core components were included as part of medication synchronization program descriptions in the available literature. Several core components were identified as consistent throughout most of the published literature. These components were the identification and enrollment of patients, inclusion of a medication review and patient assessment, the alignment of refills, a formal process for preparation of medications, and the delivery of medications and other services.This review identified several common themes of medication synchronization in the literature, which could help standardize medication synchronization within community pharmacy and facilitate future research. Themes found in this review provide the foundation upon which a consensus definition of medication synchronization can be built.}, number={11}, journal={RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY}, author={Patti, Michael and Renfro, Chelsea Phillips and Posey, Rachael and Wu, Gabrielle and Turner, Kea and Ferreri, Stefanie P.}, year={2019}, month={Nov}, pages={1281–1288} }
 @article{world workshop of oral medicine vii: a systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus_2019, url={http://dx.doi.org/10.1111/odi.13083}, DOI={10.1111/odi.13083}, abstractNote={Abstract}, journal={Oral Diseases}, year={2019}, month={Jun} }
 @article{world workshop on oral medicine
            vii
            : immunobiologics for salivary gland disease in sjögren's syndrome: a systematic review_2019, url={http://dx.doi.org/10.1111/odi.13062}, DOI={10.1111/odi.13062}, abstractNote={Abstract}, journal={Oral Diseases}, year={2019}, month={Jun} }
 @article{rackers_thomas_williamson_posey_kimmel_2018, title={Emerging literature in the Microbiota-Brain Axis and Perinatal Mood and Anxiety Disorders}, volume={95}, ISSN={["1873-3360"]}, url={https://app.dimensions.ai/details/publication/pub.1104041428}, DOI={10.1016/j.psyneuen.2018.05.020}, abstractNote={Perinatal Mood and Anxiety Disorders (PMAD) are common and can cause significant morbidity and mortality for mother and child. A healthy perinatal period requires significant adaptations; however, systems can become imbalanced resulting in depressive and anxiety symptoms. The interface between the microbiome, the immune system, and the stress system may be a model for understanding mechanisms underlying PMAD. Emerging literature from general populations regarding immune, hormone, and HPA axis changes in relation to the microbiome combined with literature on immune, gonadotropin, and stress systems in the perinatal period provides a background. We systematically investigated literature in the developing field of the microbiome in relation to PMAD. Our inclusion criteria were 1) reporting measure of maternal mood, stress, or anxious or depressed behavior; 2) in the perinatal period, defined as pregnancy through one year postpartum; and 3) reporting measure of maternal microbiome including manipulations of the microbiome through prebiotics, probiotics, or interventions with microbial byproducts. The review identified research studying associations between stress and maternal microbiome; dietary impacts on microbial composition, mood, and stress; and the relationship between the microbiome and the immune system through immunoregulatory mechanisms. Important themes identified include: the importance of studying the maternal microbiome and measures of stress, anxiety, and depression and that multi-hit models will be needed as research strives to determine the effects of multiple mechanisms working in concert.}, journal={PSYCHONEUROENDOCRINOLOGY}, author={Rackers, Hannah S. and Thomas, Stephanie and Williamson, Kelsey and Posey, Rachael and Kimmel, Mary C.}, year={2018}, month={Sep}, pages={86–96} }
 @article{patti_renfro_posey_wu_turner_ferreri_2018, title={Systematic review of medication synchronization in community pharmacy practice}, url={http://www.sciencedirect.com/science/article/pii/S1551741118304443}, DOI={https://doi.org/10.1016/j.sapharm.2018.11.008}, abstractNote={Medication non-adherence costs more than 100 billion dollars in avoidable hospitalizations yearly. As a result, community pharmacies have implemented medication synchronization programs to improve adherence. One function of most medication synchronization programs is the alignment of all of a patient's medications to refill on a single date. While aligning refills is a standard aspect of most programs, other features vary making it difficult to identify which program components lead to improved adherence.To review available literature and identify core components of medication synchronization and associated implementation techniques in community pharmacy.A systematic review was performed by searching electronic databases for studies, reviews, and other sources for grey literature discussing medication synchronization in community pharmacy settings. Studies were eligible for inclusion if they documented the operation of medication synchronization program in a community pharmacy. A framework analysis identified common themes present in the literature.Twenty-six studies met criteria for final inclusion in this review. The majority of studies were retrospective cohorts, commentaries, and implementation guides. A wide variety of core components were included as part of medication synchronization program descriptions in the available literature. Several core components were identified as consistent throughout most of the published literature. These components were the identification and enrollment of patients, inclusion of a medication review and patient assessment, the alignment of refills, a formal process for preparation of medications, and the delivery of medications and other services.This review identified several common themes of medication synchronization in the literature, which could help standardize medication synchronization within community pharmacy and facilitate future research. Themes found in this review provide the foundation upon which a consensus definition of medication synchronization can be built.}, journal={Research in Social and Administrative Pharmacy}, author={Patti, Michael and Renfro, Chelsea Phillips and Posey, Rachael and Wu, Gabrielle and Turner, Kea and Ferreri, Stefanie P.}, year={2018} }
 @article{m_lc_ce_al_2015, title={Medication therapy management interventions in outpatient settings: A systematic review and meta-analysis}, volume={175}, url={http://archinte.jamanetwork.com/article.aspx?articleid=1935933}, DOI={10.1001/jamainternmed.2014.5841}, abstractNote={IMPORTANCE
Medication therapy management (MTM) services (also called clinical pharmacy services) aim to reduce medication-related problems and their downstream outcomes.


OBJECTIVE
To assess the effect of MTM interventions among outpatients with chronic illnesses.


DATA SOURCES
MEDLINE, Cochrane Library, and International Pharmaceutical Abstracts through January 9, 2014.


STUDY SELECTION
Two reviewers selected studies with comparators and eligible outcomes of ambulatory adults.


DATA EXTRACTION AND SYNTHESIS
Dual review of titles, abstracts, full-text, extractions, risk of bias, and strength of evidence grading. We conducted meta-analyses using random-effects models.


MAIN OUTCOMES AND MEASURES
Medication-related problems, morbidity, mortality, quality of life, health care use, costs, and harms.


RESULTS
Forty-four studies met the inclusion criteria. The evidence was insufficient to determine the effect of MTM interventions on most evaluated outcomes (eg, drug therapy problems, adverse drug events, disease-specific morbidity, disease-specific or all-cause mortality, and harms). The interventions improved a few measures of medication-related problems and health care use and costs (low strength of evidence) when compared with usual care. Specifically, MTM interventions improved medication appropriateness (4.9 vs 0.9 points on the medication appropriateness index, P < .001), adherence (approximately 4.6%), and percentage of patients achieving a threshold adherence level (odds ratios [ORs] ranged from 0.99 to 5.98) and reduced medication dosing (mean difference, -2.2 doses; 95% CI, -3.738 to -0.662). Medication therapy management interventions reduced health plan expenditures on medication costs, although the studies reported wide CIs. For patients with diabetes mellitus or heart failure, MTM interventions lowered the odds of hospitalization (diabetes: OR, 0.91 to 0.93 based on type of insurance; adjusted hazard rate for heart failure: 0.55; 95% CI, 0.39 to 0.77) and hospitalization costs (mean differences ranged from -$363.45 to -$398.98). The interventions conferred no benefit for patient satisfaction and most measures of health-related quality of life (low strength).


CONCLUSIONS AND RELEVANCE
We graded the evidence as insufficient for most outcomes because of inconsistency and imprecision that stem in part from underlying heterogeneity in populations and interventions. Medication therapy management interventions may reduce the frequency of some medication-related problems, including nonadherence, and lower some health care use and costs, but the evidence is insufficient with respect to improvement in health outcomes.}, number={1}, journal={JAMA Internal Medicine}, author={M, Viswanathan and LC, Kahwati and CE, Golin and al}, year={2015}, pages={76–87} }
 @book{lux_posey_daniels_henke_durham_jonas_lohr_2014, place={Rockville, MD}, title={Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia}, volume={14}, url={http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=2007}, note={Prepared by the RTI–University of North Carolina at Chapel Hill Evidence-based Practice Center under Contract No. 290-2012-00008-I.}, number={136}, journal={Comparative Effectiveness Review}, institution={AHRQ Publication}, author={Lux, L.J. and Posey, R.E. and Daniels, L.S. and Henke, D.C. and Durham, C. and Jonas, D.E. and Lohr, K.N.}, year={2014}, month={Nov} }
 @book{mccrory_coeytaux_schmit_kraft_kosinski_mingo_vann_gilstrap_hargett_lugogo_et al._2013, title={Pulmonary Arterial Hypertension: Screening, Management, and Treatment}, institution={Agency for Healthcare Research and Quality (US)}, author={McCrory, Douglas C and Coeytaux, Remy R and Schmit, Kristine M and Kraft, Bryan and Kosinski, Andrzej S and Mingo, Alicea M and Vann, Lisa M and Gilstrap, Daniel L and Hargett, C William and Lugogo, Njira L and et al.}, year={2013} }
 @book{jones_schmit_vemulapalli_subherwal_patel_hasselblad_heidenfelder_chobot_posey_wing_et al._2013, title={Treatment Strategies for Patients With Peripheral Artery Disease}, institution={Agency for Healthcare Research and Quality (US)}, author={Jones, W Schuyler and Schmit, Kristine M and Vemulapalli, Sreekanth and Subherwal, Sumeet and Patel, Manesh R and Hasselblad, Victor and Heidenfelder, Brooke L and Chobot, Megan M and Posey, Rachael and Wing, Liz and et al.}, year={2013} }
 @book{feltner_wines_posey_jonas_2012, title={Drug Class Review Newer Diabetes Medications, TZDs, and Combinations Single Drug Addendum: Linagliptin}, author={Feltner, Cynthia and Wines, Roberta and Posey, Rachael E and Jonas, MSLS Daniel E}, year={2012} }
 @book{powers_crowley_mccrory_pendergast_posey_hadley_gray_sanders_2012, title={Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension}, institution={Agency for Healthcare Research and Quality (US)}, author={Powers, Benjamin J and Crowley, Matthew J and McCrory, Douglas C and Pendergast, Karen and Posey, Rachael and Hadley, Corey and Gray, Rebecca and Sanders, Gillian D}, year={2012} }
 @book{williams_cox_hargett_gilstrap_castillo_govert_lugogo_coeytaux_mccrory_hasselblad_et al._2012, title={Noninvasive positive-pressure ventilation (NPPV) for acute respiratory failure}, institution={Agency for Healthcare Research and Quality (US)}, author={Williams, John W and Cox, Christopher E and Hargett, C William and Gilstrap, Daniel L and Castillo, Christian E and Govert, Joseph A and Lugogo, Njira L and Coeytaux, Remy R and McCrory, Douglas C and Hasselblad, Victor and et al.}, year={2012} }
 @book{myers_mcbroom_shen_posey_gray_sanders_2012, title={Value-of-information analysis for patient-centered outcomes research prioritization}, journal={Report prepared by the Duke Evidence-based Practice Center. Patient-Centered Outcomes Research Institute}, author={Myers, Evan and McBroom, Amanda J and Shen, Lan and Posey, Rachael E and Gray, MSLS Rebecca and Sanders, Gillian D}, year={2012} }